Vermillion Company Profile (NASDAQ:VRML)

About Vermillion

Vermillion logoVermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic Substances
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: VRML
  • CUSIP:
Key Metrics:
  • Previous Close: $2.13
  • 50 Day Moving Average: $1.39
  • 200 Day Moving Average: $1.24
  • 52-Week Range: $0.76 - $2.66
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.55
  • P/E Growth: 0.00
  • Market Cap: $111.33M
  • Outstanding Shares: 52,268,000
  • Beta: 1.8
Profitability:
  • Net Margins: -778.21%
  • Return on Equity: -148.10%
  • Return on Assets: -111.43%
Debt:
  • Debt-to-Equity Ratio: 0.27%
  • Current Ratio: 3.25%
  • Quick Ratio: 3.22%
Additional Links:
Companies Related to Vermillion:

Analyst Ratings

Consensus Ratings for Vermillion (NASDAQ:VRML) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $2.00 (4.76% downside)

Analysts' Ratings History for Vermillion (NASDAQ:VRML)
Show:
DateFirmActionRatingPrice TargetDetails
1/23/2017Canaccord GenuitySet Price TargetBuy$2.00View Rating Details
8/17/2015Roth CapitalReiterated RatingBuyView Rating Details
(Data available from 2/24/2015 forward)

Earnings

Earnings History for Vermillion (NASDAQ:VRML)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/22/2017        
11/10/2016Q316($0.06)($0.07)ViewN/AView Earnings Details
8/10/2016Q216($0.09)($0.07)ViewListenView Earnings Details
5/16/2016Q116($0.09)($0.09)ViewListenView Earnings Details
3/24/2016Q415($0.10)$1.20 millionViewListenView Earnings Details
11/12/2015Q315($0.10)($0.10)ViewListenView Earnings Details
8/13/2015Q215($0.08)($0.11)$1.50 million$535.00 millionViewListenView Earnings Details
5/11/2015Q115($0.10)($0.10)ViewListenView Earnings Details
3/25/2015Q414($0.08)($0.11)$1.59 million$1.57 millionViewListenView Earnings Details
11/14/2013Q3($0.10)$319.00 million$330.00 millionViewListenView Earnings Details
8/14/2013Q2 2013($0.11)$0.32 million$0.23 millionViewListenView Earnings Details
5/15/2013Q1 2013($0.15)($0.17)$0.30 million$0.33 millionViewListenView Earnings Details
11/12/2012Q312($0.21)($0.13)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Vermillion (NASDAQ:VRML)
Current Year EPS Consensus Estimate: $-0.29 EPS
Next Year EPS Consensus Estimate: $-0.22 EPS

Dividends

Dividend History for Vermillion (NASDAQ:VRML)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Vermillion (NASDAQ:VRML)
Insider Ownership Percentage: 2.19%
Institutional Ownership Percentage: 37.74%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/17/2017Larry N FeinbergInsiderBuy617,731$1.40$864,823.40View SEC Filing  
2/13/2017Eric SchoenSVPBuy3,347$1.40$4,685.80View SEC Filing  
2/13/2017Jack W SchulerMajor ShareholderBuy974,081$1.40$1,363,713.40View SEC Filing  
2/13/2017Valerie Barber PalmieriCEOBuy10,042$1.40$14,058.80View SEC Filing  
2/13/2017Veronica Gh JordanDirectorBuy6,695$1.40$9,373.00View SEC Filing  
1/28/2016Jack W SchulerMajor ShareholderBuy1,493$1.60$2,388.80View SEC Filing  
1/25/2016Jack W SchulerMajor ShareholderBuy3,700$1.57$5,809.00View SEC Filing  
1/21/2016Jack W SchulerMajor ShareholderBuy30,700$1.46$44,822.00View SEC Filing  
1/19/2016Jack W SchulerMajor ShareholderBuy57,749$1.45$83,736.05View SEC Filing  
1/15/2016Jack W SchulerMajor ShareholderBuy8,400$1.56$13,104.00View SEC Filing  
7/14/2015Larry N FeinbergInsiderBuy512,043$1.96$1,003,604.28View SEC Filing  
12/23/2014Jack W SchulerMajor ShareholderBuy1,288,339$1.44$1,855,208.16View SEC Filing  
12/23/2014Larry N FeinbergInsiderBuy972,222$1.44$1,399,999.68View SEC Filing  
12/19/2014Peter S RoddyDirectorBuy16,502$1.44$23,762.88View SEC Filing  
11/21/2014Valerie Barber PalmieriCOOBuy3,500$1.51$5,285.00View SEC Filing  
11/20/2014James T LafranceInsiderBuy27,907$1.44$40,186.08View SEC Filing  
11/20/2014Valerie Barber PalmieriCOOBuy30,000$1.44$43,200.00View SEC Filing  
11/19/2014James T LafranceInsiderBuy41,615$1.43$59,509.45View SEC Filing  
11/18/2014Eric SchoenCAOBuy5,000$1.42$7,100.00View SEC Filing  
11/20/2013William B CreechVPBuy2,000$2.33$4,660.00View SEC Filing  
6/11/2013William B CreechVPBuy10,000$3.18$31,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Vermillion (NASDAQ:VRML)
DateHeadline
nasdaq.com logoBUZZ-U.S. STOCKS ON THE MOVE-Kraft, Unilever, Delta Natural Gas, Lumber Liquidators (NASDAQ:VRML)
m.nasdaq.com - February 21 at 4:06 PM
marketexclusive.com logoVermillion, Inc. (NASDAQ:VRML) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:VRML)
marketexclusive.com - February 21 at 8:14 AM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securiti (NASDAQ:VRML)
biz.yahoo.com - February 17 at 5:05 PM
us.rd.yahoo.com logoVermillion Announces Equity Financing of $5.6 Million (NASDAQ:VRML)
us.rd.yahoo.com - February 14 at 3:49 PM
News IconVermillion Inc VRML Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:VRML)
www.bioportfolio.com - January 26 at 2:57 AM
News IconVermillion Inc VRML Medical Equipment Deals and Alliances Profile Prices from USD $250 (NASDAQ:VRML)
www.bioportfolio.com - January 13 at 5:42 AM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:VRML)
biz.yahoo.com - January 9 at 3:53 PM
finance.yahoo.com logoVermillion Announces Reimbursement Code Updates for Overa and OVA1 (NASDAQ:VRML)
finance.yahoo.com - January 9 at 3:53 PM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:VRML)
biz.yahoo.com - January 7 at 6:22 AM
us.rd.yahoo.com logo4:06 pm Vermillion & ASPiRA LABS announce receipt of formal FDA clarification regarding ovarian cancer screening alert (NASDAQ:VRML)
us.rd.yahoo.com - January 6 at 6:31 AM
finance.yahoo.com logoVermillion and ASPiRA LABS Announce Receipt of Formal FDA Clarification Regarding Ovarian Cancer Screening Alert (NASDAQ:VRML)
finance.yahoo.com - January 4 at 4:21 PM
capitalcube.com logoETFs with exposure to Vermillion, Inc. : December 9, 2016 (NASDAQ:VRML)
www.capitalcube.com - December 9 at 3:57 PM
News IconSocietatea Nationala de Transport Gaze Naturale TRANSGAZ S.A. (TGN) - New Report Available (NASDAQ:VRML)
reports.pr-inside.com - December 1 at 1:22 AM
News IconVermillion, Inc. VRML Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:VRML)
www.bioportfolio.com - November 23 at 8:28 PM
News IconVermillion, Inc. VRML Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:VRML)
www.bioportfolio.com - November 21 at 8:50 PM
finance.yahoo.com logoVermillion Announces Appointment of Chief Medical Officer (NASDAQ:VRML)
finance.yahoo.com - November 14 at 8:31 PM
finance.yahoo.com logoVermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology and Diagnostic Forum (NASDAQ:VRML)
finance.yahoo.com - November 14 at 12:33 PM
capitalcube.com logoVermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016 (NASDAQ:VRML)
www.capitalcube.com - November 14 at 12:33 PM
seekingalpha.com logoVermillion's (VRML) CEO Valerie Palmieri on Q3 2016 Results - Earnings Call Transcript (NASDAQ:VRML)
seekingalpha.com - November 11 at 8:01 PM
finance.yahoo.com logoVermillion Reports Third Quarter 2016 Results (NASDAQ:VRML)
finance.yahoo.com - November 10 at 8:19 PM
sg.finance.yahoo.com logoVermillion reports 3Q loss (NASDAQ:VRML)
sg.finance.yahoo.com - November 10 at 8:19 PM
finance.yahoo.com logoASPiRA LABS' OVA1 Technology Receives "Level B" Recommendation in the Latest ACOG Clinical Management Guidelines for the Management of Adnexal Masses (NASDAQ:VRML)
finance.yahoo.com - November 10 at 11:58 AM
biz.yahoo.com logoQ3 2016 Vermillion Inc Earnings Release - After Market Close (NASDAQ:VRML)
biz.yahoo.com - November 10 at 11:58 AM
finance.yahoo.com logoVermillion to Report Third Quarter 2016 Financial Results and Host Investor Conference Call on November 10th (NASDAQ:VRML)
finance.yahoo.com - October 27 at 9:55 AM
finance.yahoo.com logoVermillion CEO to Present at Women in Bio - New York (NASDAQ:VRML)
finance.yahoo.com - October 19 at 7:38 PM
publicnow.com logoVermillion CEO to Present at Women in Bio – New York (NASDAQ:VRML)
www.publicnow.com - October 19 at 7:38 PM
finance.yahoo.com logo9:08 am Vermillion announces a contract agreement with CareFirst BlueCross BlueShield for their ovarian cancer risk assessment test, OVA1 (NASDAQ:VRML)
finance.yahoo.com - September 29 at 7:55 PM
publicnow.com logoASPiRA LABs OVA1® Test Now Covered By CareFirst BlueCross BlueShield (NASDAQ:VRML)
www.publicnow.com - September 29 at 7:55 PM
finance.yahoo.com logoVermillion and ASPiRA LABs Applaud the FDA's Position on Ovarian Cancer Screening (NASDAQ:VRML)
finance.yahoo.com - September 9 at 7:37 PM
publicnow.com logoVermillion and ASPiRA Labs Applaud the FDA’s Position on Ovarian Cancer Screening (NASDAQ:VRML)
www.publicnow.com - September 9 at 7:37 PM
publicnow.com logoASPiRA LABs Partners with New York Yankees Manager Joe Girardi for Ovarian Cancer Awareness Campaign Promoting Earlier Diagnosis (NASDAQ:VRML)
www.publicnow.com - September 7 at 11:53 AM
finance.yahoo.com logoVermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell with Olympic … (NASDAQ:VRML)
finance.yahoo.com - September 2 at 8:18 AM
finance.yahoo.com logoVermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell with Olympic Gymnast Shannon Miller, and NASCAR Driver Martin Truex, Jr.'s Life Partner, Sherry Pollex (NASDAQ:VRML)
finance.yahoo.com - September 1 at 8:00 PM
publicnow.com logoVermillion, Inc. Kicks Off Ovarian Cancer Awareness Month by Ringing the NASDAQ Closing Bell with Olympic Gymnast Shannon Miller, and NASCAR Driver Martin Truex, Jr.’s Life Partner, Sherry Pollex (NASDAQ:VRML)
www.publicnow.com - September 1 at 11:20 AM
capitalcube.com logoETF’s with exposure to Vermillion, Inc. : August 16, 2016 (NASDAQ:VRML)
www.capitalcube.com - August 16 at 8:14 PM
capitalcube.com logoVermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:VRML)
www.capitalcube.com - August 12 at 11:29 AM
publicnow.com logoVermillion Reports Second Quarter 2016 Results (NASDAQ:VRML)
www.publicnow.com - August 10 at 8:51 PM
sg.finance.yahoo.com logoVermillion reports 2Q loss (NASDAQ:VRML)
sg.finance.yahoo.com - August 10 at 11:25 AM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:VRML)
biz.yahoo.com - August 10 at 11:25 AM
finance.yahoo.com logoVermillion to Present Corporate Overview at the Canaccord Genuity 36th Annual Growth Conference (NASDAQ:VRML)
finance.yahoo.com - August 8 at 8:22 PM
publicnow.com logoASPiRA LABS Expands Coverage for OVA1® in California (NASDAQ:VRML)
www.publicnow.com - August 2 at 8:35 PM
finance.yahoo.com logoVermillion to Report Second Quarter 2016 Financial Results and Host Investor Conference Call on August 10th (NASDAQ:VRML)
finance.yahoo.com - July 29 at 9:00 AM
publicnow.com logoASPiRA LABS Expands Coverage for OVA1 in Texas (NASDAQ:VRML)
www.publicnow.com - July 27 at 9:48 AM
finance.yahoo.com logoASPiRA LABS Announces Strategic Michigan Coverage for OVA1 (NASDAQ:VRML)
finance.yahoo.com - July 19 at 9:15 AM
capitalcube.com logoETF’s with exposure to Vermillion, Inc. : July 18, 2016 (NASDAQ:VRML)
www.capitalcube.com - July 18 at 2:29 PM
biz.yahoo.com logoVERMILLION, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:VRML)
biz.yahoo.com - June 22 at 4:07 PM
finance.yahoo.com logoCroatia Launches Oil Exploration with 5 Blocks, $75M Investment (NASDAQ:VRML)
finance.yahoo.com - June 10 at 2:23 PM
capitalcube.com logoETF’s with exposure to Vermillion, Inc. : June 7, 2016 (NASDAQ:VRML)
www.capitalcube.com - June 7 at 5:49 PM
capitalcube.com logoVermillion, Inc. :VRML-US: Earnings Analysis: Q1, 2016 By the Numbers : June 3, 2016 (NASDAQ:VRML)
www.capitalcube.com - June 3 at 11:04 AM
finance.yahoo.com logoVermillion's CPRIT-Sponsored Pelvic Mass Registry Steering Committee Chartered (NASDAQ:VRML)
finance.yahoo.com - February 11 at 9:00 AM

Social

What is Vermillion's stock symbol?

Vermillion trades on the NASDAQ under the ticker symbol "VRML."

Where is Vermillion's stock going? Where will Vermillion's stock price be in 2017?

1 equities research analysts have issued 1-year target prices for Vermillion's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Vermillion's stock price to reach $2.00 in the next twelve months.

When will Vermillion announce their earnings?

Vermillion is scheduled to release their next quarterly earnings announcement on Wednesday, March, 22nd 2017.

Who owns Vermillion stock?

Vermillion's stock is owned by many different of institutional and retail investors. Top institutional investors include FMR LLC (10.05%), Birchview Capital LP (5.20%) and Renaissance Technologies LLC (0.57%). Company insiders that own Vermillion stock include Eric Schoen, Jack W Schuler, Larry N Feinberg, Valerie Barber Palmieri and Veronica Gh Jordan.

Who sold Vermillion stock? Who is selling Vermillion stock?

Vermillion's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC.

How do I buy Vermillion stock?

Shares of Vermillion can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Vermillion stock cost?

One share of Vermillion stock can currently be purchased for approximately $2.10.

Vermillion (NASDAQ:VRML) Chart for Friday, February, 24, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Vermillion (NASDAQ:VRML)

Earnings History Chart

Earnings by Quarter for Vermillion (NASDAQ:VRML)

Dividend History Chart

Dividend Payments by Quarter for Vermillion (NASDAQ:VRML)

Last Updated on 2/24/2017 by MarketBeat.com Staff